Quantcast

ProGenTech Partners With the China CDC to Develop an Automated Molecular Diagnostic Platform and Assays

December 18, 2008

EMERYVILLE, Calif., Dec. 18 /PRNewswire/ — ProGenTech Limited, a life
science and molecular diagnostics company based in Shanghai, China and the San
Francisco Bay Area
has signed a collaboration agreement with the China CDC to
create a joint laboratory that will focus on developing next generation
molecular diagnostic systems and assays.

Under the terms of the agreement, the joint laboratory will leverage
ProGenTech’s existing Entura instrument platform and proprietary cassettes for
the development of an integrated molecular diagnostic system. This joint
system will be specifically designed for the rapid surveillance and detection
of existing and emerging pathogens identified by the CDC in China.
Development of ProGenTech’s first fully-automated systems for sample
preparation was driven by an emphasis on affordability and usability, design
concepts the company plans to carry forward into this joint effort.

Commenting on this new relationship, Dr. XiaoYong Tong of China CDC said,
“This collaboration provides the latest molecular diagnostic technology to
enhance China CDC’s ability in the area of infectious disease detection and
prevention.”

In October of this year, ProGenTech executed key licenses to enable the
development of several assays for hospital-acquired infection targets
including MRSA/MSSA, VRE, and C. difficile. This collaboration with the China
CDC will create a unique environment for ProGenTech to rapidly expand its
product pipeline by developing infectious disease assays the China CDC sees as
the highest priority.

Dr. Trevor Hawkins, the Chairman and CEO of ProGenTech, added, “This
relationship marks an important step forward in our global diagnostics program
and gives us a unique partner in the China CDC to lead the world in products
for rapid infectious disease testing.”

ProGenTech currently markets the Entura family of nucleic acid
purification instruments in Asia; however, this collaboration will mark
ProGenTech’s first steps towards actively developing and launching diagnostics
products in the region. The China-based distributor, Team On S&T Limited, and
the China CDC plan to market and sell the joint products within their networks
once development is completed.

About ProGenTech Limited

ProGenTech Limited is a life science and molecular diagnostics company
developing instrumentation for nucleic acid and protein purification and
molecular diagnostics testing. The company was founded in 2005 and has
offices in the San Francisco Bay Area and Shanghai. ProGenTech’s first line
of sample purification instruments, the Entura product family, increases
efficiency in the lab through true walkway automation. These instruments are
compatible with the company’s unique cassettes, which allow users to isolate a
variety of nucleic acids and proteins from a variety of sample types.
ProGenTech is also developing a series of molecular diagnostic assays and a
fully-integrated instrument for detecting hospital-acquired infection targets.
Additional information about ProGenTech can be found at
http://www.progentech.com.

About China CDC

Chinese Center for Disease Control and Prevention (China CDC) has over
3000 centers in China, which serve the nation in the area of disease control
and prevention. China CDC is a member of the WHO. Additional information about
China CDC can be found at http://www.chinacdc.net.cn.

About Team On S&T Limited

Team On is a medical equipment distributor within China with great
influence in the life science and molecular diagnostic market. For more info
please call +86-10-67184281.

SOURCE ProGenTech Limited


Source: newswire



comments powered by Disqus